{"entity":{"type":"insider","cik":"0001377759","url":"/insider/0001377759","json_url":"/insider/0001377759.json","name":"Bermingham Nessan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":1,"first":"2017-12-08","last":"2017-12-08","span_basis":"filed_date"},"name_variants":[{"name":"Bermingham Nessan","source":"filing","n_filings":1,"first_seen":"2017-12-08","last_seen":"2017-12-08"}],"transactions":[{"id":4786535,"accession":"0001209191-17-064786","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-064786","line_url":"/filing/0001209191-17-064786#line-5","is_derivative":false,"issuer_cik":"0001377759","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001377759","owner_cik":"0001377759","owner_name":"Bermingham Nessan","owner_display_name":"Bermingham Nessan","owner_url":"/insider/0001377759","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94143.0,"shares_display":"94,143","price_per_share":20.821,"price_display":"20.82","price_state":"stated","total_value":1960151.403,"total_display":"1,960,151.40","total_whole":"1,960,151","shares_owned_after":458250.0,"shares_owned_after_display":"458,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-08","filed_date":"2017-12-08","scope":"insider"},{"id":4786531,"accession":"0001209191-17-064786","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-064786","line_url":"/filing/0001209191-17-064786","is_derivative":false,"issuer_cik":"0001377759","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001377759","owner_cik":"0001377759","owner_name":"Bermingham Nessan","owner_display_name":"Bermingham Nessan","owner_url":"/insider/0001377759","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131140.0,"shares_display":"131,140","price_per_share":21.136700311117888,"price_display":"21.14","price_state":"stated","total_value":2771866.8788,"total_display":"2,771,866.88","total_whole":"2,771,867","shares_owned_after":579959.0,"shares_owned_after_display":"579,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-07","filed_date":"2017-12-08","scope":"insider","n_lines":2},{"id":4786522,"accession":"0001209191-17-064786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-064786","line_url":"/filing/0001209191-17-064786","is_derivative":false,"issuer_cik":"0001377759","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001377759","owner_cik":"0001377759","owner_name":"Bermingham Nessan","owner_display_name":"Bermingham Nessan","owner_url":"/insider/0001377759","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111500.0,"shares_display":"111,500","price_per_share":20.340815790134528,"price_display":"20.34","price_state":"stated","total_value":2268000.9606,"total_display":"2,268,000.96","total_whole":"2,268,001","shares_owned_after":696000.0,"shares_owned_after_display":"696,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-06","filed_date":"2017-12-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Director, Officer (President & CEO)","n_filings":1,"first_seen":"2017-12-08","last_seen":"2017-12-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001377759","retrieved_at":"2026-08-24T05:45:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}